Cerro Pacific Wealth Advisors’s Novartis NVS Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,691	Closed	-$227K	–	148
2022 Q2	$227K	Sell	2,691 -457	-15%	-$40.1K	0.14%	132
2022 Q1	$276K	Sell	3,148 -66	-2%	-$5.71K	0.17%	113
2021 Q4	$281K	Sell	3,214 -772	-19%	-$64.1K	0.18%	111
2021 Q3	$326K	Sell	3,986 -1,438	-27%	-$129K	0.23%	105
2021 Q2	$495K	Buy	+5,424	New	+$483K	0.37%	81
2020 Q4	$841K	Buy	+8,907	New	+$778K	0.5%	63

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CCM

Cullen Capital Management New York $10.2B AUM 27.15% 1-Year Est. Return

Cerro Pacific Wealth Advisors's NVS Position: Q3 2022 in Review

Cerro Pacific Wealth Advisors sold out of Novartis (NVS) in Q3 2022, closing a stake of 2,691 shares — an estimated $227K sold.

Cerro Pacific Wealth Advisors first reported a position in NVS in Q4 2020 and held it in 6 quarters. The position peaked at $841K in Q4 2020. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

Cerro Pacific Wealth Advisors reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
Cerro Pacific Wealth Advisors sold 2,691 Novartis shares in Q3 2022, an estimated $227K.
Cerro Pacific Wealth Advisors first reported a position in Novartis in Q4 2020 and held it in 6 quarters.
Cerro Pacific Wealth Advisors's Novartis position peaked at $841K in Q4 2020.
1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.